Sensitivity to targeted therapy differs between HER2-amplified breast cancer cells harboring kinase and helical domain mutations in PIK3CA

被引：0
|
作者：
Joseph P. Garay
Rebecca Smith
Kaylyn Devlin
Daniel P. Hollern
Tiera Liby
Moqing Liu
Shanta Boddapati
Spencer S. Watson
Amanda Esch
Ting Zheng
Wallace Thompson
Darcie Babcock
Sunjong Kwon
Koei Chin
Laura Heiser
Joe W. Gray
James E. Korkola
机构：
[1] Oregon Health & Science University,Department of Biomedical Engineering
[2] University of North Carolina,Department of Genetics
[3] Chapel Hill,undefined
来源：
Breast Cancer Research | / 23卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Frequency of PIK3CA mutations in HER2+surgically resected breast cancers in a Hispanic cohort
    Munive, Carlos
    Gallo, Aly
    Neciosup, Silvia P.
    Doimi, Franco
    Dyer, Richard
    Pinto, Joseph
    Lopez-Ilasaca, Marco
    Gomez, Henry
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [42] Sensitivity for detecting PIK3CA mutations in early-stage breast cancer with droplet digital PCR
    Beaver, Julia A.
    Balukrishna, Sasidharan
    Jelovac, Danijela
    Higgins, Michaela Jane
    Jeter, Stacie
    Stearns, Vered
    Wolff, Antonio C.
    Kessler, Jill
    VanDenBerg, Dustin
    Toro, Patricia Valda
    Argani, Pedram
    Park, Ben Ho
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [43] PIK3CA Mutations May Be Discordant between Primary and Corresponding Metastatic Disease in Breast Cancer
    Jensen, Jeanette Dupont
    Laenkholm, Anne-Vibeke
    Knoop, Ann
    Ewertz, Marianne
    Bandaru, Raj
    Liu, Weihua
    Hackl, Wolfgang
    Barrett, J. Carl
    Gardner, Humphrey
    CLINICAL CANCER RESEARCH, 2011, 17 (04) : 667 - 677
  • [44] PIK3CA mutations in HER2-positive early breast cancer patients enrolled in the adjuvant randomized short-HER study
    Guarneri, V.
    Dieci, M. V.
    Bisagni, G.
    Brandes, A. A.
    Frassoldati, A.
    Cavanna, L.
    Musolino, A.
    Giotta, F.
    Rimanti, A.
    Garrone, O.
    Bertone, E.
    Cagossi, K.
    Nanni, O.
    Piacentini, F.
    Orvieto, E.
    Curtarello, M.
    Chic, N.
    D'Amico, R.
    Prat, A.
    Conte, P. F.
    ANNALS OF ONCOLOGY, 2020, 31 : S23 - S23
  • [45] PIK3CA Mutations as a Molecular Target for Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer
    Fusco, Nicola
    Malapelle, Umberto
    Fassan, Matteo
    Marchio, Caterina
    Buglioni, Simonetta
    Zupo, Simonetta
    Criscitiello, Carmen
    Vigneri, Paolo
    Dei Tos, Angelo Paolo
    Maiorano, Eugenio
    Viale, Giuseppe
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [46] Genomic landscape of HER2-negative advanced or metastatic breast cancer with PIK3CA gain-of-function mutations
    Xi, Jing
    Harnden, Kathleen
    Luo, Jingqin
    Call, Greg S.
    Mauer, Elizabeth
    Ronski, Karyn
    Ma, Cynthia X.
    Vasan, Neil
    CANCER RESEARCH, 2022, 82 (04)
  • [47] The clinical value of HER-2 overexpression and PIK3CA mutations in the older breast cancer population: a FOCUS study analysis
    Charla C. Engels
    Mandy Kiderlen
    Esther Bastiaannet
    Ronald van Eijk
    Antien Mooyaart
    Vincent T. H. B. M. Smit
    Anton J. M. de Craen
    Peter J. K. Kuppen
    Judith R. Kroep
    Cornelis J. H. van de Velde
    Gerrit Jan Liefers
    Breast Cancer Research and Treatment, 2016, 156 : 361 - 370
  • [48] A Systematic Review of the Prevalence and Diagnostic Workup of PIK3CA Mutations in HR+/HER2-Metastatic Breast Cancer
    Anderson, Elizabeth J.
    Mollon, Lea E.
    Dean, Joni L.
    Warholak, Terri L.
    Aizer, Ayal
    Platt, Emma A.
    Tang, Derek H.
    Davis, Lisa E.
    INTERNATIONAL JOURNAL OF BREAST CANCER, 2020, 2020
  • [49] The clinical value of HER-2 overexpression and PIK3CA mutations in the older breast cancer population: a FOCUS study analysis
    Engels, Charla C.
    Kiderlen, Mandy
    Bastiaannet, Esther
    van Eijk, Ronald
    Mooyaart, Antien
    Smit, Vincent T. H. B. M.
    de Craen, Anton J. M.
    Kuppen, Peter J. K.
    Kroep, Judith R.
    van de Velde, Cornelis J. H.
    Liefers, Gerrit Jan
    BREAST CANCER RESEARCH AND TREATMENT, 2016, 156 (02) : 361 - 370
  • [50] Pik3ca mutations among hormone receptor positive and HER-2 negative advanced breast cancer patients in Finland
    Heinolainen, Krista
    Saarinen, Silva
    Ellonen, Antti
    Karlsson, Antti
    Utriainen, Meri
    Vertuani, Simona
    Holm, Barbro
    CANCER RESEARCH, 2021, 81 (04)
12345